PubMed list
of Jörg Piontek, |
2024
van der Veen RE, Piontek J, Bieck M, Saiti A, Gonschior H, Lehmann M (2024) Claudin-4 polymerizes after a small extracellular claudin-3-like substitution. J. Biol. Chem. 300(10): 107693 (14 pages). doi: 10.1016/j.jbc.2024.107693 (°IF 4.0)
Nagarajan SK, Weber J, Roderer D, Piontek J (2024) C. perfringens enterotoxin-claudin pore complex: Models for structure, mechanism of pore assembly and cation permeability. bioRxiv preprint server https://www.biorxiv.org/content/10.1101/2024.08.02.605804v1
Nagarajan SK, Piontek J (2024) Molecular dynamics simulations of claudin-10a and -10b ion channels: With similar architecture, different pore linings determine the opposite charge selectivity. Int. J. Mol. Sci. 25(6): 3161 (23 pages), doi: 10.3390/ijms25063161 (°IF 4.9)
Legere EA, Baumholtz AI, Lachance JB, Archer M, Piontek J, Ryan AK (2024) Claudin-3 in the non-neural ectoderm is essential for neural fold fusion in chicken embryos. Dev. Biol. 507: 20-33. doi: 10.1016/j.ydbio.2023.12.009 (°IF 2.5)
2023
Waldow A*, Beier LS* (*shared first authorship), Arndt J, Schallenberg S, Vollbrecht C, Bischoff P, Farrera-Sal M, Loch FN, Bojarski C, Schumann M, Winkler L, Kamphues C, Ehlen L°, Piontek J° (°shared last authorship) (2023) cCPE fusion proteins as molecular probes to detect claudins and tight junction dysregulation in gastrointestinal cell lines, tissue explants and patient-derived organoids. Pharmaceutics 15(7): 1980 (23 pages). doi: 10.3390/pharmaceutics15071980 (IF 4.9)
Nagarajan SK, Klein S, Fadakar BS, Piontek J (2023) Claudin-10b cation channels in tight junction strands: Octameric-interlocked pore barrels constitute paracellular channels with low water permeability Comp. Struct. Biotechnol. J. 21: 1711-1727, doi: 10.1016/j.csbj.2023.02.009 (IF 4.4)
2022
Beier LS*, Waldow A* (*shared first authorship), Khomeijani Farahani S, Mannweiler R, Vidal-Y-Sy S, Brandner JM, Piontek J°, Günzel D° (°shared last authorship) (2022) Claudin targeting as an effective tool for directed barrier modulation of the viable epidermis. Ann. NY Acad. Sci. 1517(1): 251-265, doi: 10.1111/nyas.14879 (IF 5.2)
Hempel C*, Rosenthal R* (*shared first authorship), Fromm A, Krug SM, Fromm M, Günzel D, Piontek J (2022) Tight junction channels claudin-10b and claudin-15: Functional mapping of pore-lining residues. Ann. NY Acad. Sci. 1515(1): 129-142, doi: 10.1111/nyas.14794 (IF 5.2)
Gonschior H, Schmied C, Van der Veen R, Eichhorst J, Himmerkus N, Piontek J, Günzel D, Bleich M, Furuse M, Haucke V, Lehmann M (2022) Nanoscale segregation of
channel and barrier claudins enables paracellular ion flux. Nat. Commun. 13(1): 4985 (20 pages). doi: 10.1038/s41467-022-32533-4,
Supplement (IF 16.6) Sewerin S, Piontek J, Schönauer R, Grunewald S, Rauch A, Neuber S, Bergmann C, Günzel D*, Halbritter J*
(*shared last authorship) (2022) Defective claudin-10 causes a novel variation of HELIX syndrome
through compromised tight junction strand assembly. Genes & Dis. 9(5): 1301-1314.
doi: 10.1016/j.gendis.2021.06.006 (IF
6.8)
Zejc T, Piontek J, Schulzke JD, Fromm M, Ervens J*, Rosenthal R* (*shared
last authorship) (2022)
Clinical significance of claudin expression in oral squamous cell carcinoma.
Int. J. Mol. Sci.
Book chapter
Beier LS, Piontek J, Piontek A, Protze J, Kobelt D, Walther W (2022) Claudin-targeted suicide gene therapy for claudin-overexpressing tumor cells by using modified Clostridium perfringens enterotoxin (CPE). In: Walter W (ed), Gene therapy of cancer. Methods Mol. Biol. 2521: 173-188. doi: 10.1007/978-1-0716-2441-8_9
2021
Dias MC, Quesada AO, Soldati S, Boesch F, Gruber I, Hildbrand T, Soenmez D, Khire T, Witz G, McGrath JL, Piontek J, Kondoh M, Deutsch U, Zuber B, Engelhardt B (2021) Brain endothelial tricellular junctions as novel sites for T-cell diapedesis across the blood-brain barrier. J. Cell Sci. 134(8): jcs253880 (19 pages), doi: org/10.1242/jcs.253880, Supplement PDF (IF 5.2)
Pahle J, Kobelt D, Aumann J, Behrens D, Daberkow O, Mokritzkij M, Piontek J, Stein U, Walther W (2021) Effective oncoleaking treatment of pancreatic cancer by claudin-targeted suicide gene therapy with Clostridium perfringens enterotoxin (CPE). Cancers 13(17): 4393 (26 pages). doi: 10.3390/cancers13174393, Supplement, (IF 6.6)
2020
Hempel C, Protze J, Altun E, Riebe B, Piontek A, Fromm A, Lee IM, Saleh T, Günzel D, Krause G, Piontek J (2020) Assembly of tight junction strands: Claudin-10b and claudin-3 form homo-tetrameric building blocks that polymerize in a channel-independent manner. J. Mol. Biol. 432(7): 2405-2427 (IF 5.5) [PubMed] [WebPage] [PDF] [Supplementary Figures S1-S11] [Supplementary Table S1]
Piontek A, Eichner M, Zwanziger D, Beier LS, Protze J, Walter W, Theurer S, Schmid KW, Führer-Sakel D, Piontek J*, Krause G* (*shared last authorship) (2020) Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin. Mol. Oncol. 14(2) :261-276 (IF 6.6) [PubMed] [WebPage] [PDF]
Rosenthal R, Günzel D, Piontek J, Krug SM, Ayala-Torres C, Hempel C, Theune D, Fromm M (2020) Claudin-15 forms a water channel through the tight junction with distinct function compared to claudin-2. Acta Physiol. 228(1): e13334 (15 pages) (IF 6.3) [PubMed] [WebPage] [PDF]
(Editorial Commentary on this article: Alexander RT (2020) Claudin-15 is not a drag! Acta Physiol. 228(1): e13397 [PubMed] [WebPage] [PDF])
Review
Piontek J, Krug SM, Protze J, Krause G, Fromm M (2020) Molecular architecture and assembly of the tight junction backbone. BBA - Biomembranes 1862(7): 183279 (15 pages) (IF 3.7) [Part of Special Volume "The vertebrate epithelial apical junctional complex", Hervé JC ed.] [PubMed] [WebPage] [PDF] [Supplement]
2019
Beier LS, Rossa J, Woodhouse S, Bergmann S, Kramer HB, Protze J, Eichner M, Piontek A, Vidal-y-Sy S, Brandner JM, Krause G, Zitzmann N, Piontek J (2019) Use of modified Clostridium perfringens enterotoxin fragments for claudin targeting in liver and skin cells. Int. J. Mol. Sci. 20(19): 4774 (20 pages) (IF 4.6) [PubMed] [WebPage] [PDF] [Supplement PDF]
2018